Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press activity in Media Coverage, and Taconic's commitment to being Models For Life™.

Rodents in Space Will Show How Genes Are Affected by Microgravity

An article published this month in Seeker.com highlights the most recent Rodent Research space mission which launched to the International Space Station on December 5th, 2018 carrying 40 BALB/cAnNTac mice from Taconic Biosciences. The study had three specific aims: To evaluate muscle atrophy under microgravity conditions To quantify changes in tissue-specific molecular markers and To characterize the effects of microgravity on bone density during and after the...

Read More

H.I.G. Capital Completes Acquisition of Taconic Biosciences

Boston, MA - February 7, 2019 - H.I.G. Capital ("H.I.G."), a leading global private equity investment firm with $30 billion of equity capital under management, is pleased to announce that one of its affiliates has partnered with the management team of Taconic Biosciences, Inc., ("Taconic" or the "Company") to support the Company's growth as a leading global provider of research models and services to the pharmaceutical, biotechnology,...

Read More

Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences

Rensselaer, New York — January 31, 2019 - Taconic Biosciences' Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective January 14, Ms. Sandy took the company's top leadership position. Dr. Rosenthal, who held the position for four and a half years, continues his association with Taconic, leading external growth initiatives as Chief Innovation Officer and holds...

Read More

Taconic Biosciences' Animals Complete Most Recent Mission to the International Space Station

Rensselaer, NY — January 17, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight...

Read More

Taconic Biosciences Announces R&D Collaboration with UNC-Chapel Hill

Rensselaer, NY — November 30, 2018 - Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces a research and development collaboration with the University of North Carolina at Chapel Hill (UNC). The collaboration commercializes animal model discoveries coming from the University, expanding Taconic's proprietary commercial products portfolio and ultimately increasing access to key resources necessary for developing treatments for human diseases....

Read More

Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis

An article recently divulged in Nature Communications highlights the importance of mouse models in studying the progression of pancreatic cancer, with xenograft studies performed on Taconic Biosciences' NCR nude mice. Specifically, analyzing tumors that have become resistant to KRAS or MEK inhibition is of key importance to developing anti-cancer drugs. By targeting a specific pathway of nucleotide biosynthesis, the researchers were able to reverse this resistance and...

Read More

Love Letters to Animal Care Technicians

Taconic Biosciences proudly partnered with Transnetyx on its Love Letters: Counting Every Second video. The Love Letters video series chronicles patients who have received a therapeutic treatment that was developed utilizing animal models. The patient reads a "love letter" to the animal care technicians and others who played key roles in making their treatment possible. Set in Taconic's hometown of Albany, New York, Love Letters: Counting Every...

Read More

Schistosoma mansoni Egg-Released IPSE/alpha-1 Dampens Inflammatory Cytokine Responses via Basophil Interleukin (IL)-4 and IL-13

Frontiers in Immunology features this study which discusses potential mechanisms by which schistosomes (Schistosoma mansoni) could control inflammation in a host. In order to evaluate the immune response after a Schistosoma mansoni infection, sections of S. mansoni-infected paraffin-embedded mouse liver tissue from female C57BL/6NTac mice from Taconic Biosciences were used for immunohistochemistry. Utilizing the mouse animal model was essential for furthering the research into inflammation caused by...

Read More

Mucociliary Clearance in Mice Measured by Tracking Trans-tracheal Fluorescence of Nasally Aerosolized Beads

Researchers from the University of North Carolina School of Medicine obtained Black 6 mice from Taconic Biosciences for this study on Mucociliary Clearance (MCC). The authors concluded that their technique of "tracking trans-tracheal fluorescence of nasally aerosolized beads" has multiple advantages over current techniques for studying MCC in mice: "Mucociliary clearance (MCC) is the first line of defense in clearing airways. In genetically engineered mice, each component...

Read More

Taconic Supports Critical Polio Efforts

Partnering with Global Polio Eradication Initiative (GPEI), Taconic helps to create a world without polio. GPEI is a public-private partnership led by national governments with five partners -- the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children's Fund (UNICEF), and the Bill & Melinda Gates Foundation. Its goal is to eradicate polio worldwide. There is no...

Read More